4//SEC Filing
Trapp Todd A 4
Accession 0001415889-22-003909
CIK 0000815094other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:26 PM ET
Size
13.8 KB
Accession
0001415889-22-003909
Insider Transaction Report
Form 4
ABIOMED INCNASD
Trapp Todd A
Vice President, CFO
Transactions
- Sale
Common Stock, $0.01 par value
2022-04-04$333.00/sh−1,000$333,000→ 13,063 total
Holdings
- 7,000
Stock Option (Right to Buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 3,737
Stock Option (Right to Buy)
Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (0 underlying) - 6,530
Stock Option (Right to Buy)
Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying)
Footnotes (4)
- [F1]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- [F2]This price represents the sale price of the transactions on the reported date at $333.00. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F4]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001638242
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 4:26 PM ET
- Size
- 13.8 KB